Revolax Fine 1.1 ml

Revolax Fine 1.1 ml

Revolax Fine 1.1 ml brings a lighter correction profile to professional treatment planning, using hyaluronic acid and lidocaine for fine-line refinement. The result is a product with a defined place in the range rather than a one-size-fits-all option.

Where This Product Fits

For a professional buyer, the deciding points are concrete. Revolax Fine 1.1 ml should be assessed through its material profile, intended objective and exact presentation.

• Formulation focus: cross-linked hyaluronic acid and lidocaine
• Main professional objectives: fine-line refinement
• Most relevant treatment areas: crow’s feet, lips and perioral area, and forehead lines
• Presentation details: 24mg/ml, 1.1 ml, and 1.1ml

1. Filler and Gel Profile

Revolax Fine 1.1 ml is positioned as a lighter correction profile associated with fine lines, delicate areas and superficial refinement. The relationship between its formulation, strength, presentation and professional objective defines this exact product more clearly than its category name alone.

2. How the Gel Supports Correction

Revolax Fine 1.1 ml is designed to provide physical support within professionally selected tissue planes. Its practical behaviour is linked to the gel profile: softer variants favour integration and refinement, while more structured variants are selected when projection, contour definition or volume replacement is the priority. This variant is positioned toward delicate correction and smoother integration.

3. Main Correction Goals

• Facial contour refinement
• Fine-line refinement
• Skin hydration

4. Facial Areas Suited to This Profile

Revolax Fine 1.1 ml is commonly associated with:

• Forehead
• Crow’s feet
• Lips and perioral area

The practitioner determines whether Revolax Fine 1.1 ml fits the selected area, tissue plane and treatment objective.

5. Formulation and Syringe Specifications

The formulation includes cross-linked hyaluronic acid, hyaluronic acid, lidocaine hydrochloride, and vitamin C. The sealed label for Revolax Fine 1.1 ml remains the controlling reference for its exact ingredient statement.

• Product: Revolax Fine 1.1 ml
• Product type: Professional injectable dermal filler
• Revolax Fine 1.1 ml: Variant profile: A lighter correction profile associated with fine lines, delicate areas and superficial refinement
• Reported strength or volume: 1.1 ml, 24mg/mL, 3mg/ml, and 1.1ml
• Revolax Fine 1.1 ml: Reported formulation: cross-linked hyaluronic acid, hyaluronic acid, lidocaine hydrochloride, and vitamin C
• Package details: 1 syringe, 1.1 ml, 1.1ml, and 1.1 ml Syringe
• Revolax Fine 1.1 ml: Storage profile: do not freeze, protect from direct light, and room-temperature storage is mentioned

6. Expected Integration and Result Profile

For Revolax Fine 1.1 ml, the visible profile is linked to the selected correction goal. Integration, projection and contour support should be assessed according to the named gel variant, treatment plane, area and quantity used rather than applying one duration claim to the entire product family.

7. Package and Storage Information

For the product, the reported package presentation includes 1 syringe, 1.1 ml, 1.1ml, and 1.1 ml Syringe. The available product information specifies do not freeze, protect from direct light, and room-temperature storage is mentioned. The sealed outer box and current instructions remain the controlling handling reference.

8. Fine, Deep or Volume: Where This Variant Fits

For Revolax Fine 1.1 ml, the product should be compared with neighbouring variants by gel profile, not simply by brand name. Fine or Soft versions generally favour delicate refinement; Deep or Mid versions provide more support for folds and contour; Volume, Implant or Sub-Q versions sit toward structural correction and projection. this presentation is positioned as a lighter correction profile associated with fine lines, delicate areas and superficial refinement.

9. Frequently Asked Questions

What is Revolax Fine 1.1 ml?

For Revolax Fine 1.1 ml, this presentation is a professional injectable dermal filler positioned as a lighter correction profile associated with fine lines, delicate areas and superficial refinement. Its page is built around the exact formulation and presentation rather than a generic description of the category.

What is the main purpose of Revolax Fine 1.1 ml?

For this presentation, its product profile centres on facial contour refinement, fine-line refinement, and skin hydration. The final treatment objective and technique are selected by a qualified professional.

What does Revolax Fine 1.1 ml contain?

For this formulation, available product information describes cross-linked hyaluronic acid, hyaluronic acid, lidocaine hydrochloride, and vitamin C.

Which areas are associated with Revolax Fine 1.1 ml?

For Revolax Fine 1.1 ml, the product information associates this formulation with forehead, crow’s feet, and lips and perioral area. Suitability and placement depend on the exact product instructions and individual assessment.

How is Revolax Fine 1.1 ml supplied?

this presentation is described with 1 syringe, 1.1 ml, 1.1ml, and 1.1 ml Syringe. Current outer-box information remains the controlling reference for the received market presentation.

What makes this exact version different?

For Revolax Fine 1.1 ml, the named variant should be compared with neighbouring variants by gel profile, not simply by brand name. Fine or Soft versions generally favour delicate refinement; Deep or Mid versions provide more support for folds and contour; Volume, Implant or Sub-Q versions sit toward structural correction and projection. this formulation is positioned as a lighter correction profile associated with fine lines, delicate areas and superficial refinement.

10. Professional Use

Manufacturer-Confirmed Details

For this formulation, across identifies REVOLAX as a Korean hyaluronic-acid filler range divided into Fine, Deep and Sub-Q according to application. The manufacturer describes the range for wrinkle improvement and tissue restoration. The product brochure supports the family structure; the exact variant label remains controlling for syringe volume, lidocaine status, needle and intended placement.